Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M01AB01	INDOCID	B	Indometacin - 100mg	100mg	Suppository	424,910 L.L
M01AB01	INDOMEL	G	Indometacin - 100mg	100mg	Suppository	222,694 L.L
M01AE01	IBUSOL	G	Ibuprofen - 100mg/5ml	100mg/5ml	Suspension	309,724 L.L
B03AC	IVIRON	G	Iron (sucrose) - 100mg/5ml	100mg/5ml	Injectable concentrated solution	1,745,203 L.L
L01CE02	IRINOTECAN GP PHARM	G	Irinotecan HCl trihydrate - 100mg/5ml	100mg/5ml	Injectable concentrated solution	5,239,642 L.L
L01CE02	IRINOTECAN HYDROCHLORIDE	G	Irinotecan HCl - 100mg/5ml	100mg/5ml	Injectable concentrate for solution	2,085,644 L.L
L01CE02	IRINOTECAN THYMOORGAN	G	Irinotecan HCl - 100mg/5ml	100mg/5ml	Injectable concentrated solution	6,111,796 L.L
L01CE02	IRNOCAM 100	G	Irinotecan HCl - 100mg/5ml	100mg/5ml	Injectable solution	7,320,947 L.L
J06BB04	IMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB	BioHuman	Hepatitis B immunoglobulin (human) - 100UI/ml	100UI/ml	Injectable solution	6,853,730 L.L
J06BA02	IG VENA	BioHuman	Human normal immunoglobulin - 10g/200ml	10g/200ml	Injectable solution	55,897,163 L.L
C01DA08	ISDN	G	Isosorbide dinitrate - 10mg	10mg	Tablet	311,771 L.L
C01DA08	ISODEX	G	Isosorbide dinitrate - 10mg	10mg	Tablet	138,224 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 120mg/2.4ml	120mg/2.4ml	Injectable solution	59,776,110 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 120mg/2.4ml	120mg/2.4ml	Injectable solution	59,776,110 L.L
L01EF01	IBRANCE	B	Palbociclib - 125mg	125mg	Capsule	172,164,216 L.L
L01EF01	IBRANCE	B	Palbociclib - 125mg	125mg	Tablet, film coated	172,164,216 L.L
L01EL01	IMBRUVICA	B	Ibrutinib - 140mg	140mg	Tablet, film coated	194,761,420 L.L
N05AX13	INVEGA SUSTENNA	B	Paliperidone palmitate - 150mg	150mg	Injectable suspension, prolonged release	27,480,995 L.L
C09CA04	IBECARD 150- IPS	G	Irbesartan - 150mg	150mg	Tablet, film coated	564,414 L.L
C09CA04	IRBAVEL 150	G	Irbesartan - 150mg	150mg	Tablet, film coated	564,414 L.L
C09CA04	IRBESARTAN ARROW	G	Irbesartan - 150mg	150mg	Tablet	470,345 L.L
G01AF05	IFENEC	G	Econazole nitrate - 150mg	150mg	Ovule	546,944 L.L
L01EA05	ICLUSIG	B	Ponatinib - 15mg	15mg	Tablet, film coated	103,555,839 L.L
D10BA01	ISOSUPRA LIDOSE	G	Isotretinoin - 16mg	16mg	Capsule, hard	1,826,282 L.L
R03BB04	INHALEX	G	Tiotropium bromide - 18mcg	18mcg	Capsule, inhalation	1,906,913 L.L
J01DH03	INVANZ	B	Ertapenem - 1g	1g	Injectable concentrated powder for solution	3,785,604 L.L
J06BA02	IG VENA	BioHuman	Human normal immunoglobulin - 1g/20ml	1g/20ml	Injectable solution	7,474,948 L.L
L01EK01	INLYTA	B	Axitinib - 1mg	1mg	Tablet, film coated	57,595,789 L.L
J06BA02	IG VENA	BioHuman	Human normal immunoglobulin - 2.5g/50ml	2.5g/50ml	Injectable solution	17,011,323 L.L
M01AE01	IBUPROFEN B. BRAUN	G	Ibuprofen - 200mg/50ml	200mg/50ml	Injectable solution	161,261 L.L